Latest Prostate cancer Stories
Decipher test results show potential utility in determining benefit of hormone therapy and timing of salvage radiation therapy CHICAGO, May 30, 2015 /PRNewswire/ --
Significant reduction in risk of death observed in those patients with most common risk factors that drive poor outcomes in prostate cancer BOTHELL, Wash.
Results from the Phase 2 MMY2002 trial (Abstract LBA8512) featured in the official press program of the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) CHICAGO
A multi-center study led by NewYork-Presbyterian/Columbia University Medical Center has found that a urine test can determine if a patient has high-grade prostate cancer with 92 percent accuracy.
SAN DIEGO, May 29, 2015 /PRNewswire/ -- Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients,
NEW YORK, May 29, 2015 /PRNewswire/ -- World-renowned prostate surgeon and New York Urologist, Dr.
VANCOUVER and HOUSTON, May 28, 2015 /PRNewswire/ - ESSA Pharma Inc.
DUBLIN, May 28, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/57tc8j/drug_delivery_in) has announced the addition of Jain PharmaBiotech's
New data from over 1,500 patients provide additional therapeutic insights into potential of Decipher GRIDTM for new populations of men with prostate cancer SAN DIEGO, May 28, 2015
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.
More Images (2 images) »